Protein Microarrays as a Tool to Analyze Antibody Responses to Variant Surface Antigens Expressed on the Surface of Plasmodium falciparum-Infected Erythrocytes.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2022
Historique:
entrez: 26 7 2022
pubmed: 27 7 2022
medline: 29 7 2022
Statut: ppublish

Résumé

Enzyme-linked immunosorbent assays (ELISAs) remain the gold standard for measuring antibodies, but are time-consuming and use significant amounts of precious sample and reagents. Protein microarrays represent an appealing alternative, particularly for studies focused on large gene families such as those encoding variant surface antigens in the malaria parasite Plasmodium falciparum. Such microarrays represent an ideal high-throughput platform to study antibody responses to hundreds of malaria parasite variant surface antigens at once, providing critical insights into the development of natural immunity to malaria. We describe the essential background and approach to run an assay using a P. falciparum microarray populated with variant surface antigens. This allows the user to define serologic profiles and identify serodominant antigens that represent promising targets for vaccine or therapeutic development.

Identifiants

pubmed: 35881357
doi: 10.1007/978-1-0716-2189-9_25
doi:

Substances chimiques

Antibodies, Protozoan 0
Antigens, Protozoan 0
Antigens, Surface 0
Protozoan Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

343-358

Informations de copyright

© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Cham GKK, Turner L, Lusingu J et al (2009) Sequential, ordered acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 domains. J Immunol 183:3356–3363. https://doi.org/10.4049/jimmunol.0901331
doi: 10.4049/jimmunol.0901331 pubmed: 19675168
Crompton PD, Kayala MA, Traore B et al (2010) A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A 107:6958–6963. https://doi.org/10.1073/pnas.1001323107
doi: 10.1073/pnas.1001323107 pubmed: 20351286 pmcid: 2872454
Marsh K, Howard RJ (1986) Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. Science 231:150–153. https://doi.org/10.1126/science.2417315
doi: 10.1126/science.2417315 pubmed: 2417315
Travassos MA, Niangaly A, Bailey JA et al (2018) Children with cerebral malaria or severe malarial anaemia lack immunity to distinct variant surface antigen subsets. Sci Rep 8:6281. https://doi.org/10.1038/s41598-018-24462-4
doi: 10.1038/s41598-018-24462-4 pubmed: 29674705 pmcid: 5908851
Bailey JA, Pablo J, Niangaly A et al (2015) Seroreactivity to a large panel of field-derived Plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 variants reflects seasonal and lifetime acquired responses to malaria. Am J Trop Med Hyg 92:9–12. https://doi.org/10.4269/ajtmh.14-0140
doi: 10.4269/ajtmh.14-0140 pubmed: 25294612 pmcid: 4347399
Bailey JA, Berry AA, Travassos MA et al (2020) Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination. Sci Rep 10:3952. https://doi.org/10.1038/s41598-020-60551-z
doi: 10.1038/s41598-020-60551-z pubmed: 32127565 pmcid: 7054363
Boudová S, Walldorf JA, Bailey JA et al (2017) Mother-newborn pairs in Malawi have similar antibody repertoires to diverse malaria antigens. Clin Vaccine Immunol 24:e00136. https://doi.org/10.1128/CVI.00136-17
doi: 10.1128/CVI.00136-17 pubmed: 28835359 pmcid: 5629668
Stucke EM, Niangaly A, Berry AA et al (2019) Serologic responses to the PfEMP1 DBL-CIDR head structure may be a better indicator of malaria exposure than those to the DBL-α tag. Malar J 18:273. https://doi.org/10.1186/s12936-019-2905-9
doi: 10.1186/s12936-019-2905-9 pubmed: 31409360 pmcid: 6692945
Travassos MA, Coulibaly D, Bailey JA et al (2015) Differential recognition of terminal extracellular Plasmodium falciparum VAR2CSA domains by sera from multigravid, malaria-exposed Malian women. Am J Trop Med Hyg 92:1190–1194. https://doi.org/10.4269/ajtmh.14-0524
doi: 10.4269/ajtmh.14-0524 pubmed: 25918203 pmcid: 4458824
Travassos MA, Niangaly A, Bailey JA et al (2013) Seroreactivity to Plasmodium falciparum erythrocyte membrane protein 1 intracellular domain in malaria-exposed children and adults. J Infect Dis 208:1514–1519. https://doi.org/10.1093/infdis/jit339
doi: 10.1093/infdis/jit339 pubmed: 23901079 pmcid: 3789569
Zhou AE, Berry AA, Bailey JA et al (2019) Antibodies to peptides in semiconserved domains of RIFINs and STEVORs correlate with malaria exposure. mSphere 4:13
doi: 10.1128/mSphere.00097-19
Davies DH, Liang X, Hernandez JE et al (2005) Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci U S A 102:547–552. https://doi.org/10.1073/pnas.0408782102
doi: 10.1073/pnas.0408782102 pubmed: 15647345 pmcid: 545576
Hedde PN, Abram TJ, Jain A et al (2020) A modular microarray imaging system for highly specific COVID-19 antibody testing. Lab Chip 20:3302–3309. https://doi.org/10.1039/D0LC00547A
doi: 10.1039/D0LC00547A pubmed: 32743622 pmcid: 8462184

Auteurs

Albert E Zhou (AE)

Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Aarti Jain (A)

Vaccine R&D Center, Department of Physiology and Biophysics, University of California Irvine, Irvine, CA, USA.

Rie Nakajima (R)

Vaccine R&D Center, Department of Physiology and Biophysics, University of California Irvine, Irvine, CA, USA.

Biraj Shrestha (B)

Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Emily M Stucke (EM)

Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Sudhaunshu Joshi (S)

Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Kathy A Strauss (KA)

Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Per N Hedde (PN)

Department of Pharmaceutical Sciences, University of California Irvine, Irvine, CA, USA.

Andrea A Berry (AA)

Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Philip L Felgner (PL)

Vaccine R&D Center, Department of Physiology and Biophysics, University of California Irvine, Irvine, CA, USA.

Mark A Travassos (MA)

Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. mtravass@som.umaryland.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH